Gui‐Ge Hou

Crystal structure of ( E )-4-(4-(3,5-dimethylpiperidin-1-yl)benzylidene)-6,8-dimethoxy-3,4-dihydrobenzo[ b ]oxepin-5( 2H )-one, C 26 H 31 NO 4

Abstract C 26 H 31 NO 4 , triclinic, P 1 ̅ $̅{1}$ (no. 2), a = 8.5191(3) Å, b = 9.6375(3) Å, c = 14.2811(3) Å, α = 79.101(2) ° , β = 77.159(2) ° , γ = 84.410(3) ° , V = 1120.69(6) Å 3 , Z = 2, R gt ( F ) = 0.0405(4), wR ref ( F 2 ) = 0.1166(4), T = 293K.

Crystal structure of ( E )-2-(4-(1 H -pyrazol-1-yl)benzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2 H )-one, C 21 H 18 N 2 O 2

Abstract C 21 H 18 N 2 O 2 , monoclinic, P 2 1 /c (no. 14), a = 16.6187(3) Å, b = 14.8732(3) Å, c = 6.8099(1) Å, β = 92.157(2)°, V = 1682.03(5) Å 3 , Z = 4, R gt ( F ) = 0.0410, w R ref ( F 2 ) = 0.1277, T = 293 K.